{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:23:31Z","timestamp":1790396611602,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007950","name":"Tanta University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007950","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In the recent decades, prostaglandins were recommended as a new therapeutic modality of stable vitiligo with promising efficacy. Therefore, we designed the current work to compare the significance of two different subtypes of prostaglandins [prostaglandin E2 (PGE2) versus prostaglandin F2 alpha (PGF2\u03b1)], assisted with NB-UVB phototherapy, in treatment of stable vitiligo. This study was conducted on 30 patients with stable non-segmental vitiligo. Three approximately similar vitiliginous areas were chosen in each patient and assigned into 3 groups. Each group treated with intradermal injection of either PGE2 (group I), PGF2\u03b1 (group II), or saline as placebo (group III) at frequency once\/week for 12 weeks. Concomitantly, all groups received NB-UVB phototherapy twice weekly for 3 months. The outcomes of this study discovered that the therapeutic efficacy of intradermal injection of either PGE2 or PGF2\u03b1 assisted with NB-UVB phototherapy was comparable with non-significant difference between them in spite of being significantly higher than NB-UVB alone. However, there were a significantly earlier onset of repigmentation and higher degree of satisfaction regarding areas treated with PGE2 than those treated with PGF2\u03b1. In conclusion, both PGF2\u03b1 and PGE2 intradermal injection could be considered as quite simple and affordable techniques in the treatment of stable vitiligo with no reported side effects and good patient satisfaction.<\/jats:p>","DOI":"10.1007\/s00403-023-02700-8","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T12:02:15Z","timestamp":1692360135000},"page":"2647-2653","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy of prostaglandin E2 versus prostaglandin F2 alpha assisted with narrowband-UVB in stable vitiligo"],"prefix":"10.1007","volume":"315","author":[{"given":"Yomna Mazid El-Hamd","family":"Neinaa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myada Abd Elmohsen","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal Mohamed","family":"El Maghraby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab Abd Elsamd","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,18]]},"reference":[{"issue":"6","key":"2700_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1159\/000506103","volume":"236","author":"C Bergqvist","year":"2020","unstructured":"Bergqvist C, Ezzedine K (2020) Vitiligo: a review. Dermatology 236(6):571\u2013592","journal-title":"Dermatology"},{"issue":"4","key":"2700_CR2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1365-2133.2008.08923.x","volume":"160","author":"R Kapoor","year":"2009","unstructured":"Kapoor R, Phiske MM, Jerajani HR (2009) Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo. Br J Dermatol 160(4):861\u2013863","journal-title":"Br J Dermatol"},{"issue":"12","key":"2700_CR3","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1046\/j.1365-4362.2002.01612.x","volume":"41","author":"D Parsad","year":"2002","unstructured":"Parsad D, Pandhi R, Dogra S et al (2002) Topical prostaglandin analog (PGE2) in vitiligo: a preliminary study. Int J Dermatol 41(12):942\u2013945","journal-title":"Int J Dermatol"},{"issue":"1","key":"2700_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13175","volume":"33","author":"K Nowroozpoor Dailami","year":"2020","unstructured":"Nowroozpoor Dailami K, Hosseini A, Rahmatpour Rokni G et al (2020) Efficacy of topical latanoprost in the treatment of eyelid vitiligo: a randomized, double-blind clinical trial study. Dermatol Ther 33(1):e13175","journal-title":"Dermatol Ther"},{"key":"2700_CR5","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1111\/dth.12011","volume":"25","author":"TM Lotti","year":"2012","unstructured":"Lotti TM, Hercogov\u00e1 J, Schwartz RA et al (2012) Treatments of vitiligo: what\u2019s new at the horizon. Dermatol Ther 25:S32\u2013S40","journal-title":"Dermatol Ther"},{"issue":"5","key":"2700_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/ijd.12631","volume":"54","author":"TS Anbar","year":"2015","unstructured":"Anbar TS, El-Ammawi TS, Abdel-Rahman AT et al (2015) The effect of latanoprost on vitiligo: a preliminary comparative study. Int J Dermatol 54(5):587\u2013593","journal-title":"Int J Dermatol"},{"issue":"2","key":"2700_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14813","volume":"34","author":"YME Neinaa","year":"2021","unstructured":"Neinaa YME, Lotfy SS, Ghaly NR et al (2021) A comparative study of combined microneedling and narrowband ultraviolet B phototherapy versus their combination with topical latanoprost in the treatment of vitiligo. Dermatol Ther 34(2):e14813","journal-title":"Dermatol Ther"},{"issue":"4","key":"2700_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/09546634.2019.1658860","volume":"32","author":"SA Eldelee","year":"2021","unstructured":"Eldelee SA, Gheida SF, Sarhan NI, at al. (2021) Evaluation of the effect of combined intralesional injection of prostaglandin F2\u03b1 with narrow band UVB phototherapy in treatment of resistant cases of vitiligo. J Dermatol Treat 32(4):383\u2013390","journal-title":"J Dermatol Treat"},{"issue":"4","key":"2700_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4103\/0974-2077.172192","volume":"8","author":"P Thakur","year":"2015","unstructured":"Thakur P, Sacchidanand S, Nataraj HV et al (2015) A study of hair follicular transplantation as a treatment option for vitiligo. J Cutan Aesthet Surg 8(4):211\u2013217","journal-title":"J Cutan Aesthet Surg"},{"issue":"6","key":"2700_CR10","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s13555-020-00447-y","volume":"10","author":"L Migayron","year":"2020","unstructured":"Migayron L, Boniface K, Seneschal J (2020) Vitiligo, from physiopathology to emerging treatments: a review. Dermatol Ther (Heidelb) 10(6):1185\u20131198","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"6","key":"2700_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/dth.12383","volume":"29","author":"IV Korobko","year":"2016","unstructured":"Korobko IV, Lomonosov KM (2016) A pilot comparative study of topical latanoprost and tacrolimus in combination with narrow-band ultraviolet B phototherapy and microneedling for the treatment of nonsegmental vitiligo. Dermatol Ther 29(6):437\u2013441","journal-title":"Dermatol Ther"},{"key":"2700_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3889\/oamjms.2018.059","volume":"6","author":"T Lotti","year":"2018","unstructured":"Lotti T, Wollina U, Tcherenev G et al (2018) An innovative therapeutic for vitiligo: experience with the use of fraxel herbium laser, topical latanoprost and successive irradiation with UVA-1 laser. Open access Maced J Med Sci 6:49\u201351","journal-title":"Open access Maced J Med Sci"},{"issue":"3","key":"2700_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1034\/j.1600-0749.2000.130305.x","volume":"13","author":"G Prota","year":"2000","unstructured":"Prota G, Vincensi MR, Napolitano A et al (2000) Latanoprost stimulates eumelanogenesis in iridial melanocytes of cynomolgus monkeys. Pigment cell Res 13(3):147\u2013150","journal-title":"Pigment cell Res"},{"issue":"11","key":"2700_CR14","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1111\/ijd.16307","volume":"61","author":"NA Nagui","year":"2022","unstructured":"Nagui NA, El-Tartoushy SA, Rashed LA et al (2022) Assessment of prostaglandin F2-alpha (PGF2\u03b1) in lesional and nonlesional skin of vitiligo patients. Int J Dermatol 61(11):1390\u20131396","journal-title":"Int J Dermatol"},{"issue":"5","key":"2700_CR15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.0906-6705.2005.00270.x","volume":"14","author":"S Sasaki","year":"2005","unstructured":"Sasaki S, Hozumi Y, Kondo S (2005) Influence of prostaglandin F2 alpha and its analogues on hair regrowth and follicular melanogenesis in a murine model. Exp Dermatol 14(5):323\u2013328","journal-title":"Exp Dermatol"},{"issue":"1","key":"2700_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0733-8635(05)70149-2","volume":"18","author":"RM Halder","year":"2000","unstructured":"Halder RM, Young CM (2000) New and emerging therapies for vitiligo. Dermatol Clin 18(1):79\u201389","journal-title":"Dermatol Clin"},{"key":"2700_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1001\/jamadermatol.2014.1875","volume":"151","author":"HW Lim","year":"2015","unstructured":"Lim HW, Grimes PE, Agbai O et al (2015) Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial. JAMA Dermatol 151:42\u201350","journal-title":"JAMA Dermatol"},{"issue":"1","key":"2700_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1468-3083.2009.03346.x","volume":"24","author":"TS Anbar","year":"2010","unstructured":"Anbar TS, El-Ammawi TS, Barakat M et al (2010) Skin pigmentation after NB-UVB and three analogues of prostaglandin F (2alpha) in guinea pigs: a comparative study. J Eur Acad Dermatol Venereol 24(1):28\u201331","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"2700_CR19","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/j.1468-3083.2009.03233.x","volume":"23","author":"TS Anbar","year":"2009","unstructured":"Anbar TS, Abdel-Raouf H, Awad SS et al (2009) The hair follicle melanocytes in vitiligo in relation to disease duration. J Eur Acad Dermatol Venereol 23(8):934\u2013939","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"2700_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1600-0781.2006.00222.x","volume":"22","author":"TS Anbar","year":"2006","unstructured":"Anbar TS, Westerhof W, Abdel-Rahman AT et al (2006) Evaluation of the effects of NB-UVB in both segmental and non-segmental vitiligo affecting different body sites. Photodermatol Photoimmunol Photomed 22(3):157\u2013163","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"4","key":"2700_CR21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1034\/j.1600-0749.2003.00070.x","volume":"16","author":"Y Gauthier","year":"2003","unstructured":"Gauthier Y, Andre M, Taieb A (2003) A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 16(4):322\u2013332","journal-title":"Pigment Cell Res"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02700-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-023-02700-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02700-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T08:06:58Z","timestamp":1695283618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-023-02700-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,18]]},"references-count":21,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["2700"],"URL":"https:\/\/doi.org\/10.1007\/s00403-023-02700-8","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,18]]},"assertion":[{"value":"10 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}